| URL | https://www.fiercepharma.com/manufacturing/hikma-e |
| Source | Fierce Pharma |
| Date Published | 06/08/2026 |
| Author Name | Joseph Keenan |
| Company/Division name | Hikma Pharmaceuticals |
| Parent company | Hikma Pharmaceuticals |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 50 |
| Year reshoring announced: | 2026 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 216 |
| Country(ies) from which reshored: | United Kingdom |
| City reshored to: | Columbus |
| State(s) reshored to: | OH |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | pharmaceuticals |